CAMP and hepatocellular carcinoma: Furthermore, hCAP18/LL-37 expression can be significantly induced by 1,25(OH)2D3 in HCC cells and in xenograft tumor tissue, which in turn suppresses the antitumor growth activity of 1,25(OH)2D3 in HCC xenograft tumors.